Article
Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.
The Journal of biological chemistry - 11 Jan 2002
Schneider Mark, Boffa Michael, Stewart Ronald, Rahman Mona, Koschinsky Marlys, Nesheim Michael
Abstract excerpt
Thrombin-activable fibrinolysis inhibitor (TAFI) is a carboxypeptidase B-like zymogen that is activated to TAFIa by plasmin, thrombin, or the thrombin-thrombomodulin complex. The enzyme TAFIa attenuates clot lysis by removing lysine residues from a fibrin clot. Screening of nine human cDNA libraries indicated a common variation in TAFI at position 325 (Ile-325 or Thr-325). This is in addition to the variation at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
